Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19 : A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin

© 2021 Samotij et al..

The global pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is emerging. Various cutaneous manifestations have been observed in patients with SARS-CoV-2 infection, yet exacerbations of psoriasis have been reported sporadically. Acrodermatitis continua of Hallopeau (ACH) is an uncommon, sterile pustular dermatosis involving one or more digits. In some rare cases, ACH may evolve into generalized pustular psoriasis (GPP), which is a severe, and potentially life-threatening, form of psoriasis that manifests itself with widespread eruptions of pustules. We describe the first case of a patient in whom ACH abruptly progressed into GPP during COVID-19. A combination of infliximab and acitretin was used allowing swift clinical improvement.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Biologics : targets & therapy - 15(2021) vom: 04., Seite 107-113

Sprache:

Englisch

Beteiligte Personen:

Samotij, Dominik [VerfasserIn]
Gawron, Ewelina [VerfasserIn]
Szczęch, Justyna [VerfasserIn]
Ostańska, Elżbieta [VerfasserIn]
Reich, Adam [VerfasserIn]

Links:

Volltext

Themen:

Biologic therapy
Biologics
Case Reports
Coronavirus
Psoriasis
Pustular psoriasis
SARS-CoV-2

Anmerkungen:

Date Revised 07.05.2021

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.2147/BTT.S302164

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM325010269